Advancements in Anticoagulation Reversal and Surgical Management of Intracerebral Hemorrhage

The chapter explores the latest concepts in hemostasis and anti-coagulation reversal, emphasizing risk-benefit analysis and the role of pharmacists in surgical management of intracerebral hemorrhage (ICH). It discusses the importance of prompt anticoagulation reversal and blood pressure control before surgical intervention, highlighting challenges and strategies such as the code ICH bundle. The conversation also touches on time-sensitive interventions and ongoing research focusing on non-anticoagulated cerebral hemorrhage patients.